New Zealand vs Thailand: Protecting minority investors: Strength of minority investor
New Zealand
43 DB15-20 methodology
in 2019
Thailand
43 DB15-20 methodology
in 2019
New Zealand rank
3rd
Thailand rank
3rd
Protecting minority investors: Strength of minority investor over time
- New Zealand
- Thailand
How they compare
New Zealand currently reports 43 DB15-20 methodology against 43 DB15-20 methodology in Thailand, a difference of 0 DB15-20 methodology.
The two have swapped places 1 time across 7 shared years of data; in 2013 it was New Zealand ahead.
New Zealand ranks 3rd and Thailand ranks 3rd of 191 countries.
New Zealand has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher protecting minority investors: strength of minority investor, New Zealand or Thailand?
- New Zealand, at 43 DB15-20 methodology against 43 DB15-20 methodology in Thailand as of 2019.
- What is the difference in protecting minority investors: strength of minority investor between New Zealand and Thailand?
- 0 DB15-20 methodology, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Thailand?
- 7 years are reported by both, from 2013 to 2019.
- How do New Zealand and Thailand rank globally for protecting minority investors: strength of minority investor?
- New Zealand ranks 3rd and Thailand ranks 3rd of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Strength of minority investor protection index (0-50) (DB15-20 methodology). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The strength of minority investor protection index is the sum of the extent of disclosure index, extent of director liability index, ease of shareholder suits index, extent of shareholder rights index, extent of ownership and control index and extent of corporate transparency index. The index is computed based on the methodology in the DB15-20 studies.